The Defense of the Mieza Compound

The differences between winning and losing intellectual property strategies are often subtle. Adopted best practices often only establish a place in the contest. Actually winning can take much more. Join the new Head of IP at Mieza Therapeutics as he seeks to defend Mieza Therapeutic’s new compound, a combination product that promises revolutionary treatment for Idiopathic Pneumonia. Through a series of IP strategy war games disguised as dreams he learns that patents alone will not win the day and that often the best defense needs a good offense as well. The Defense of the Mieza Compound is the second in a series of IP strategy books written by Think IP Strategy. This book focuses on the protection and exploitation of IP in Life Sciences. The first edition (The Defense of the Mieza HChip) was focused on the Tech industry. Additional titles in the series will address manufacturing, entertainment, consumer products, and other industries.